GLADNEY DAN W 4
4 · ReShape Lifesciences Inc. · Filed Apr 20, 2018
Insider Transaction Report
Form 4
GLADNEY DAN W
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2018-04-18+4,164,281→ 4,164,281 totalExercise: $0.65Exp: 2028-04-18→ Common stock (4,164,281 underlying)
Holdings
- 1,925
Common Stock, $0.01 par value per share
Footnotes (1)
- [F1]Subject to the employee's continued service, 25% of shares will vest on the one-year anniversary of April 18, 2018 and the remaining 75% of shares will vest in as nearly equal amounts as possible on the last day of the next 36 months thereafter.